- Home
- ADT vs CAI Comparison
ADT vs CAI Comparison
Compare ADT & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.81
N/A
Current Price
$21.50
Company Overview
Basic Information| Metric | ADT | CAI |
|---|---|---|
| Founded | 1874 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.0B |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ADT | CAI |
|---|---|---|
| Price | $7.81 | $21.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $9.25 | ★ $34.71 |
| AVG Volume (30 Days) | ★ 13.8M | 2.5M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $5,112,859,000.00 | $649,062,000.00 |
| Revenue This Year | $6.12 | $81.66 |
| Revenue Next Year | $3.60 | $33.47 |
| P/E Ratio | $11.31 | ★ N/A |
| Revenue Growth | 6.29 | ★ 112.02 |
| 52 Week Low | $7.28 | $21.18 |
| 52 Week High | $8.94 | $42.50 |
Technical Indicators
Market Signals| Indicator | ADT | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 31.92 |
| Support Level | $7.70 | $21.18 |
| Resistance Level | $8.15 | $23.00 |
| Average True Range (ATR) | 0.22 | 1.30 |
| MACD | 0.00 | -0.26 |
| Stochastic Oscillator | 21.49 | 13.07 |
Price Performance
Historical Comparison ADT
CAI
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.